STK3 is a therapeutic target for a subset of acute myeloid leukemias

Acute myeloid leukemia (AML) is characterized by uncontrolled proliferation and accumulation of immature myeloblasts, which impair normal hematopoiesis. While this definition categorizes the disease into a distinctive group, the large number of different genetic and epigenetic alterations actually s...

Descripción completa

Detalles Bibliográficos
Autores principales: Camgoz, Aylin, Paszkowski-Rogacz, Maciej, Satpathy, Shankha, Wermke, Martin, Hamann, Martin V., von Bonin, Malte, Choudhary, Chunaram, Knapp, Stefan, Buchholz, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986655/
https://www.ncbi.nlm.nih.gov/pubmed/29876001
http://dx.doi.org/10.18632/oncotarget.25238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986655/
https://www.ncbi.nlm.nih.gov/pubmed/29876001
http://dx.doi.org/10.18632/oncotarget.25238

Ejemplares similares